To develop evidence-based clinical algorithms for community acquired-acute respiratory tract infections CA-ARTI and assess the diagnostic accuracy and the clinical utility of point-of-care tests (POCT) for specific groups of patients, clinical findings, and settings
To develop evidence-based URS’s to support future development and implementation of rapid diagnostics to reduce antimicrobial resistance (AMR) for CA-ARTI, and to refine the methods and processes to make them applicable to POC diagnostic developments for other infectious disease indications
To create a technical roadmap that incorporates recommendations for short- and long-term goals to help companies and research institutions prioritize investment decisions in the field of CA-ARTI diagnostics.
https://www.value-dx.eu/wp-content/uploads/2024/11/Screenshot-2024-11-06-172749.png7011150Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2024-11-06 16:39:132024-11-06 16:45:07Concluding Interview with project lead Em. Prof. Herman Goossens
https://www.value-dx.eu/wp-content/uploads/2024/10/clinical-algorithm-image.png532800Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2024-10-21 13:25:012024-10-21 13:36:51Developing a Clinical Algorithm to support Etiological Diagnosis of CARTIs
https://www.value-dx.eu/wp-content/uploads/2024/10/groepsfoto.png26123060Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2024-10-18 10:01:232024-10-18 10:01:23VALUE-Dx Closing Conference: celebrating 5.5 years of collaborative research
https://www.value-dx.eu/wp-content/uploads/2024/04/Untitled-3.png9951488Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2024-04-22 11:33:552024-04-22 14:55:43PRUDENCE and ADEQUATE-paediatric studies: the final steps